New York Blood Center Ventures

New York Blood Center Ventures (NYBC Ventures) is the strategic venture capital arm of the New York Blood Center, dedicated to investing in early-stage life science companies. The fund focuses on innovations in hematology, transfusion medicine, infectious diseases, and regenerative medicine, particularly those involving cell and gene therapies. By leveraging the extensive research infrastructure and clinical expertise of the New York Blood Center, NYBC Ventures provides portfolio companies with unique strategic advantages beyond capital. The firm typically targets seed and Series A investments, aiming to accelerate the translation of breakthrough science into life-saving clinical applications. Its mission is to improve patient outcomes by supporting the next generation of blood-related healthcare technologies.